Three Oxfordshire firms have been shortlisted for Cleantech Venture Day in London, an established investment pitching event that brings low carbon, sustainable tech firms together with investors.
Eco-laundry service OXWASH, modular building specialist Green Unit and cleantech energy firm Verditek will be among 24 national firms pitching to potential funders at Cleantech Venture Day on February 12. The event is organised by Cambridge Cleantech, Oxfordshire Greentech and Avanto Ventures, and will be hosted by KPMG at its London head office.
Lewis Knight of Oxfordshire Greentech is impressed by the line-up of Oxfordshire participants: “Our members selected to present at CleanTech Venture Day are the first Oxfordshire firms to take part. The process is highly competitive, with over 100 nationally important SMEs applying, so I think it proves the strength of our sustainable and low-carbon tech sector here in Oxfordshire.”
Tom de Wilton, chief operating officer of OXWASH, adds: “We are delighted to have been selected to pitch, and we can’t wait to discuss our plans to clean up the dirty little secret of the laundry industry with our sustainable, innovative and future-proof model.”
The three shortlisted Oxfordshire firms are:
Green Unit which designs and manufactures modular, ultra-low carbon ‘ARC’ eco-buildings, used for offices, residential buildings and classrooms.
OXWASH, an on-demand laundry and dry cleaning service known for its sustainable approach to laundry, textile and garment care by minimising waste and detrimental environmental impact.
Verditek plc, which commercialises clean technology solutions such as highly efficient and light-weight photovoltaic cells, including the first to incorporate graphene.
Cleantech Venture Days were established in 2006. Since then, more than 200 companies have pitched their ideas and more than £500m has been invested.
Cambridge Cleantech chief executive Martin Garratt says: “In the process of paring down the entries, we were delighted with the quality of all these investment-ready and innovative companies. Everything from wearable technology to zero carbon accommodation, smart meters, hydropower and solar power will now be presented to investors.”
Using its proprietary tech, a biotech company has discovered antibodies leading to the development of drug discovery programmes in kidney disease and cancer.
Oxford biotech company e-therapeutics is offering its powerful network-biology-and AI-based drug discovery platform to help tackle the Covid-19 pandemic.
Researchers in Oxford and Zurich have used artificial intelligence (AI) and computer visualisation technology to detect changes in colon cancer cells that could be connected to the ‘expression’ of some smell-sensing genes.